| 영문 | polysaccharide | 한글 | 다당류 |
|---|---|---|---|
| 설명 | 가수분해에 의하여 한 분자에서 두 개 이상의 단당류를 생성하는 탄수화물을 통틀어 이르는 말. 즉, 여러 개의 단당이 탈수 축합한 고분자량 당질이다. 동일 종류의 단당으로 이루어진 것을 단순다당(호모다당)이라고 하며, 복수종의 단당으로 구성된 것을 복합다당(헤테로다당)이라고 한다. 분자 속에 우론산이나 황산기를 많이 함유하고 강한 음전하를 갖는 복합다당은 산성 다당 혹은 뮤코다당이라고도 하며, 보통 단백질에 통합하여 존재하는 점에서 프로테오글리칸으로서 분류된다. 지질과 결합하고 있는 것은 당지질로 총징된다. 단순다당은 구성단당 또는 기원 당의 어미에 ‘-an'을 붙여 명명한다. 예를 들어 글루칸, 푸룩탄, 만난 등. 복합다당에서는 어미에 ’글리칸, -glycan'을 붙인다. 2. 덱스트란과 같이 큰 분자량을 가지며, 물에 녹지 아니하거나 교상액膠狀液을 이루는 당류. 단일 다당류와 복합 다당류로 나눈다. 녹말, 글리코겐, 셀룰로오스 따위가 있다. |
||
| 영문 | vaccine | 한글 | 백신 |
|---|---|---|---|
| 설명 | 전염병에 대하여 인공적으로 면역을 주기 위해 생체에 투여하는 항원의 하나. 병원체 및 독소에 대한 방어기구를 강화할 목적으로 사용되는 미생물제제를 말한다. 프랑스의 미생물학자 L. 파스퇴르에 의하여 제창된 용어로서, 어떤 감염증에 대하여 인공적으로 면역을 얻기 위하여 그 병원 미생물 또는 그 독소액에 적당한 조작을 가하여 만든 것을 말한다. |
||
| IDT | immune diffusion test; instillation delivery time; intradermal typhoid [vaccine] |
|---|---|
| TAB | total autonomic blockage; typhoid, paratyphoid A, and paratyphoid B [vaccine] |
| TABC | total aerobic bacteria count; typhoid, paratyphoid A, paratyphoid B, and paratyphoid C [vaccine] |
| TABT | typhoid, paratyphoid A, paratyphoid B, and tetanus toxoid [vaccine] |
| TABTD | typhoid, paratyphoid A, paratyphoid B, tetanus toxoid, and diphtheria toxoid [vaccine] |
| TF | Typhoid fever |
|---|---|
| C-Ps | C polysaccharide |
| CP | Capsular polysaccharide |
| EPS | Extracellular polysaccharide |
| NSP | Nonstarch polysaccharide |
| typhoid-paratyphoid A and B vaccine | A suspension of killed typhoid and paratyphoid A and B bacilli. See: typhoid vaccine. Synonym: TAB vaccine. (05 Mar 2000) |
|---|---|
| typhoid vaccine | A suspension of Salmonella typhi inactivated either by heat or by chemical (acetone) with an added preservative; in the U.S., the combined typhoid and paratyphoid A and B vaccine's have been largely replaced by the monovalent typhoid vaccine because of the lack of evidence of effectiveness of paratyphoid A and paratyphoid B ingredients. (05 Mar 2000) |
| pneumococcal polysaccharide | A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule. Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar. (05 Mar 2000) |
| polysaccharide | <biochemistry> Polymers of (arbitrarily) more than about ten monosaccharide residues linked glycosidically in branched or unbranched chains. (18 Nov 1997) |
| polysaccharide deacetylase | <enzyme> Involved in bacteriophage penetration of bacteria Registry number: EC 3.5.1.- (26 Jun 1999) |
| polysaccharide-lyases | <enzyme> A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. Registry number: EC 4.2.2. (12 Dec 1998) |
| polysaccharide pyruvyltransferase | <enzyme> Catalyses the pyruvylation of capsular polysaccharides; phosphoenolpyruvate is donor at the lipid-bound saccharide stage of various bacterial polysaccharides Registry number: EC 2.2.1.- Synonym: capsular polysaccharide pyruvyltransferase (26 Jun 1999) |
| polysaccharide sulfate esters | Sulfate esters of polysaccharides often found in cell walls. (05 Mar 2000) |
| C polysaccharide | <microbiology> Polysaccharide released by pneumococci which contains galactosamine 6 phosphate and phosphoryl choline. C-reactive protein is so called because it will precipitate this polysaccharide through an interaction with the phosphoryl choline. (18 Nov 1997) |
| specific soluble polysaccharide | A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule. Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar. (05 Mar 2000) |
| abdominal typhoid | <disease, microbiology> An infectious febrile illness usually spread by contamination of food, milk or water supplies with Salmonella typhi, either directly by sewage, indirectly by flies or by faulty personal hygiene. There are less than 600 cases per year in the us. Asymptomatic carriers harbor the organism in their gallbladder and excrete it in their stools for years. Average incubation time is 10-14 days. Fever, diarrhoeal stools (often bloody), abdominal pain, malaise and a rose coloured rash on the upper abdomen are seen. Severe cases may progress to delirium and obtundation. Complications include glomerulonephritis. Treatment includes intravenous fluids and antibiotics (chloramphenicol or ampicillin). Vaccines are recommended for travel to endemic areas. (27 Sep 1997) |
| ambulatory typhoid | walking typhoid |
| apyretic typhoid | Typhoid fever in which the temperature does not rise more than a degree or two. (05 Mar 2000) |
| bilious typhoid of Griesinger | An acute infection characterised by recurrent episodes of pyrexia alternating with asymptomatic intervals of apparent recovery. This condition has worldwide distribution and is caused by spirochetes of the genus borrelia. (12 Dec 1998) |
| provocation typhoid | An accelerated onset of typhoid fever, sometimes of unusual severity, resulting from typhoid-paratyphoid A and B (T.A.B.) vaccination late in the incubation period. Walking typhoid, typhoid fever without much prostration, the patient being up and around and sometimes working. Synonym: ambulatory typhoid, latent typhoid. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|